Table 3.

Barriers and facilitators to pharmacogenomic screening implementation.

	Perceived by Stakeholder
	Patient	Community Pharmacist	Hospital Pharmacist	Physician
Barriers
Practical experience is limited	No	Yes	Yes	Yes
Need for further postgraduate education	No	Yes	Yes	No
Rely on computer systems for application	No	Yes	Yes	Yes
Need for education about PGx application	No	Yes	Yes	Yes
Practical barriers within computer systems	No	Yes	Yes	Yes
Lack of information, specifically about exact implications of PGx screening results	Yes	No	No	No
Unclear allocation of responsibilities among healthcare practitioners	Yes	Yes	Yes	Yes
Facilitators
Positive attitude towards PGx	Yes	Yes	Yes	Yes
DPWG guidelines are generally well adhered to	No	No	No	Yes